2m 2m 2m 2m 2m 2m 2m
MBX BIO (MBX)
NASDAQ
$58.54+$1.99 (+3.52%)
Price as of Oct 02, 2026 4:49 PM EDT- $2.7BMarket Cap
- 237.61%1-Year Change
- BiotechnologyIndustry
MBX BIO (MBX)
$58.54+$1.99 (+3.52%)
MBX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $56.55 | ||
Change | -$2.07 (-3.53%) | ||
Open | $58.47 | ||
High | $60.20 | ||
Low | $56.15 | ||
Previous Close | $58.62 | ||
Volume | 434,148 | ||
30-Day Average Volume | 516,459 | ||
1-Week Change | 2.09% | ||
1-Month Change | -7.19% | ||
1-Year Change | 237.61% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 48.2M | ||
Total Assets | $435.9M | ||
Market Cap | $2.7B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$37.1M | ||
Free Cash Flow | -$23.5M | ||
EBIT | -$37.1M | ||
EBITDA | -$37.0M | ||
Net Working Capital | $404.2M | ||
EPS | -$0.78 | ||
Enterprise Value/EBITDA | -72 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -73 | ||
PEG | 1 | ||
Price/Free Cash Flow | -116 | ||
Price/Operating Cash Flow | -120 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue